<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2018-574-580</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2620</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Выбор оптимального опросника оценки качества жизни, связанного со здоровьем, у пациентов с системной красной волчанкой</article-title><trans-title-group xml:lang="en"><trans-title>SELECTION OF AN OPTIMAL HEALTH-RELATED QUALITY-OF-LIFE QUESTIONNAIRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>Л. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyeva</surname><given-names>L. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><email xlink:type="simple">evagolland@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асеева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aseeva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соловьев</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Solovyev</surname><given-names>S. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>08</day><month>11</month><year>2018</year></pub-date><volume>56</volume><issue>5</issue><fpage>574</fpage><lpage>580</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьева Л.Д., Асеева Е.А., Соловьев С.К., Глухова С.И., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Воробьева Л.Д., Асеева Е.А., Соловьев С.К., Глухова С.И.</copyright-holder><copyright-holder xml:lang="en">Vorobyeva L.D., Aseeva E.A., Solovyev S.K., Glukhova S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2620">https://rsp.mediar-press.net/rsp/article/view/2620</self-uri><abstract><p>Цель исследования – обоснование выбора опросника для оценки качества жизни, связанного со здоровьем (КЖСЗ), у пациентов с системной красной волчанкой (СКВ).Материал и методы. В исследование включено 328 пациентов (298 женщин и 30 мужчин) с достоверной СКВ, соответствующих критериям SLICC 2012 г. Средний возраст больных составил 34,4±11,5 года, длительность заболевания – 106,3±97,9 мес. Всем пациентам проводилась оценка текущей активности заболевания по индексу SLEDAI-2K и органных повреждений при помощи индекса повреждения SLICC (ИП). КЖСЗ оценивалось с помощью опросников SF-36 и LupusQoL, которые пациенты заполняли самостоятельно.Результаты и обсуждение. Оценка с помощью обоих опросников выявила значительное снижение КЖСЗ по всем шкалам. Сопоставимые шкалы SF-36 и LupusQoL высоко достоверно коррелируют между собой: «Физическое здоровье» и «Физическое функционирование» (r=0,8); «Эмоциональное здоровье» и «Психологическое здоровье» (r=0,4); шкалы опросников «Боль» (r=-0,3), «Усталость» и «Жизнеспособность» (r=-0,7). Активность заболевания имеет статистически значимое влияние на «Планирование» (р&lt;0,0004), «Интимные отношения» (р&lt;0,003), «Зависимость от других людей» (р&lt;0,03), «Образ тела» (р&lt;0,007), которые не могут быть оценены общим опросником SF-36, а имеются только в LupusQol. Как SF-36, так и LupusQol одинаково отражают изменения КЖСЗ при наличии необратимых органных повреждений. Поскольку поражения суставов, кожи и нервной системы значительно затрагивают такие шкалы, как «Планирование», «Интимные отношения», «Зависимость от других людей» и «Образ тела» пациентов с СКВ, то при наличии этих изменений опросником выбора являетсяLupusQol.Заключение. При проведении научных и клинических исследований целесообразно использовать оба опросника для большей объективизации данных.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to provide a rationale for selecting a health-related quality of life (HRQOL) questionnaire in patients with systemic lupus erythematosus (SLE).Subjects and methods. The investigation enrolled 328 patients (298 women and 30 men) with documented SLE who met the 2012 Systemic Lupus International Collaborating Clinic (SLICC) criteria. The patients’ mean age was 34.4±11.5 years; the disease duration was 106.3±97.9 months. All the patients underwent an assessment of the current activity of the disease by the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and organ damages by the SLICC damage index (DI). HRQOL was assessed using the 36-item Short-Form Health Survey (SF-36) and Lupus Quality of Life (LupusQol) questionnaires, which had been filled out by the patients.Results and discussion. The assessment using both questionnaires revealed a considerable decline in HRQOL for all domains. There was a highly significant correlation among the comparable SF-36 and LupusQoL domains: «Physical Health» and «Physical Functioning» (r=0.8), «Emotional Health» and «Psychological Health» (r=0.4), «Pain» (r=-0.3), «Fatigue», and «Vitality» (r=-0.7). Disease activity has a statistically significant effect on «Planning» (p&lt;0.0004), «Intimate Relationships» (p&lt;0.003), «Dependence on Other People» (p&lt;0.03), and «Body Image» (p&lt;0.007), which cannot be assessed using the 36-item Short-Form Health Survey (SF-36) questionnaire, but which are contained only in the LupusQol questionnaire. Both SF-36 and LupusQol equally reflect HRQOL changes in the presence of irreversible organ damages. Since lesions of the joints, skin and nervous system significantly affect domains, such as «Planning», «Intimate Relationships», «Dependence on Other People», and «Body Image» in SLE patients, LupusQol is the choice of questionnaire when these changes are present. When conducting scientific and clinical research, it is advisable to use both questionnaires for greater objectification of data. When conducting researches and clinical trials, it is advisable to use both questionnaires for greater data objectification.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>системная красная волчанка</kwd><kwd>качество жизни</kwd><kwd>связанное со здоровьем</kwd><kwd>SF-36</kwd><kwd>LupusQol</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic lupus erythematosus</kwd><kwd>health-related quality of life</kwd><kwd>SF-36</kwd><kwd>LupusQoL</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Trupin L, Tonner M, Yazdany J, et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol. 2008;35:1782-8. PMC 2875144.</mixed-citation><mixed-citation xml:lang="en">Trupin L, Tonner M, Yazdany J, et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol. 2008;35:1782-8. PMC 2875144.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alarcon G, McGwin G, Uribe A, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (lumina). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51:465-74. doi: 10.1002/art.20409</mixed-citation><mixed-citation xml:lang="en">Alarcon G, McGwin G, Uribe A, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (lumina). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51:465-74. doi: 10.1002/art.20409</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Haupt M, Millen S, Janner M, et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64:1618-23. doi: 10.1136/ard.2004.029926</mixed-citation><mixed-citation xml:lang="en">Haupt M, Millen S, Janner M, et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64:1618-23. doi: 10.1136/ard.2004.029926</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kuriya B, Gladman D, Ibanеz D, Urowitz M. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008;59:181-5. doi: 10.1002/art.23339</mixed-citation><mixed-citation xml:lang="en">Kuriya B, Gladman D, Ibanеz D, Urowitz M. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008;59:181-5. doi: 10.1002/art.23339</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lau C, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol. 2009;5:400-4. doi: 10.1038/nrrheum.2009.106</mixed-citation><mixed-citation xml:lang="en">Lau C, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol. 2009;5:400-4. doi: 10.1038/nrrheum.2009.106</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McElhone K, Abbott J, Gray J, Williams A, Teh L. Patient perspective of systemic lupus erythematosus in relation to healthrelated quality of life concepts: a qualitative study. Lupus. 2010;19:1640-7. doi: 10.1177/0961203310378668</mixed-citation><mixed-citation xml:lang="en">McElhone K, Abbott J, Gray J, Williams A, Teh L. Patient perspective of systemic lupus erythematosus in relation to healthrelated quality of life concepts: a qualitative study. Lupus. 2010;19:1640-7. doi: 10.1177/0961203310378668</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005;32(9):1706-8.</mixed-citation><mixed-citation xml:lang="en">Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005;32(9):1706-8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">McElhone K, Abbott J, Sutton C. Sensitivity to Change (Responsiveness) and Minimal Important Differences of the LupusQoL in patients with Systemic Lupus Erythematosus. Arthritis Care Res. 2016;68(10):1505-13. doi: 10.1002/acr.22850</mixed-citation><mixed-citation xml:lang="en">McElhone K, Abbott J, Sutton C. Sensitivity to Change (Responsiveness) and Minimal Important Differences of the LupusQoL in patients with Systemic Lupus Erythematosus. Arthritis Care Res. 2016;68(10):1505-13. doi: 10.1002/acr.22850</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">McElhone K, Abbott J, Shelmardine J, et al. Development and validation of a disease-specific health-related quality of life measure, the lupusQoL, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007;57(6):972-9. doi: 10.1002/art.22881</mixed-citation><mixed-citation xml:lang="en">McElhone K, Abbott J, Shelmardine J, et al. Development and validation of a disease-specific health-related quality of life measure, the lupusQoL, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007;57(6):972-9. doi: 10.1002/art.22881</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Асеева ЕА, Воробьева ЛД, Соловьев СК и др. Психометрические свойства русскоязычной версии специфического опросника LupusQol для оценки качества жизни, связанного со здоровьем, у пациентов с системной красной волчанкой. Научно-практическая ревматология. 2018;56(2):164-72 [Aseeva EA, Vorobyeva LD, Solovyev SK, et al. The psychometric properties of a Russian version of the disease-specific LupusQol questionnaire assessing the health-related quality of life in patients with systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(2):164-72 (In Russ.)]. doi: 10.14412/1995-4484-2018-164-172</mixed-citation><mixed-citation xml:lang="en">Асеева ЕА, Воробьева ЛД, Соловьев СК и др. Психометрические свойства русскоязычной версии специфического опросника LupusQol для оценки качества жизни, связанного со здоровьем, у пациентов с системной красной волчанкой. Научно-практическая ревматология. 2018;56(2):164-72 [Aseeva EA, Vorobyeva LD, Solovyev SK, et al. The psychometric properties of a Russian version of the disease-specific LupusQol questionnaire assessing the health-related quality of life in patients with systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(2):164-72 (In Russ.)]. doi: 10.14412/1995-4484-2018-164-172</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Touma Z, Gladman D, Ibanez D, Urowitz M. Is there an advantage over SF-36 with a quality of life measure that is specifiс to systemic lupus erythematosus? J Rheumatol. 2011 Sep;38(9):1898-905. doi: 10.3899/jrheum.110007</mixed-citation><mixed-citation xml:lang="en">Touma Z, Gladman D, Ibanez D, Urowitz M. Is there an advantage over SF-36 with a quality of life measure that is specifiс to systemic lupus erythematosus? J Rheumatol. 2011 Sep;38(9):1898-905. doi: 10.3899/jrheum.110007</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yilmaz-Oner S, Oner C, Dogukan FM, et al. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clin Rheumatol. 2016;35(3):617-22. doi: 10.1007/s10067-015-2930-1</mixed-citation><mixed-citation xml:lang="en">Yilmaz-Oner S, Oner C, Dogukan FM, et al. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clin Rheumatol. 2016;35(3):617-22. doi: 10.1007/s10067-015-2930-1</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Carrasco M, Mendoza-Pinto C, Cardiel MH, et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL. Lupus. 2012;21:1219-24. doi: 10.1177/0961203312456749</mixed-citation><mixed-citation xml:lang="en">Garcia-Carrasco M, Mendoza-Pinto C, Cardiel MH, et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL. Lupus. 2012;21:1219-24. doi: 10.1177/0961203312456749</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu T, Tam L, Lee V. Relationship Between Flare and Healthrelated Quality of Life in Patients with Systemic Lupus Erythematosus. Arthritis Rheum. 2009 Sep 15;61(9):1159-67. doi: 10.1002/art.24725</mixed-citation><mixed-citation xml:lang="en">Zhu T, Tam L, Lee V. Relationship Between Flare and Healthrelated Quality of Life in Patients with Systemic Lupus Erythematosus. Arthritis Rheum. 2009 Sep 15;61(9):1159-67. doi: 10.1002/art.24725</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004;43(12):1580-6. doi: 10.1093/rheumatology/keh392</mixed-citation><mixed-citation xml:lang="en">Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004;43(12):1580-6. doi: 10.1093/rheumatology/keh392</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Conti F, Perricone C, Reboldi G, et al. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. Lupus. 2014;23:743-51. doi: 10.1177/0961203314524466</mixed-citation><mixed-citation xml:lang="en">Conti F, Perricone C, Reboldi G, et al. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. Lupus. 2014;23:743-51. doi: 10.1177/0961203314524466</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pamuk O, Onat A, Donmez S, et al. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients. Lupus. 2015;24(8):816-21. doi: 10.1177/0961203314565412</mixed-citation><mixed-citation xml:lang="en">Pamuk O, Onat A, Donmez S, et al. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients. Lupus. 2015;24(8):816-21. doi: 10.1177/0961203314565412</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Duarte C, Abreu P, Couto M, et al. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage. Acta Reumatol Port. 2010 Jan-Mar;35(1):30-5.</mixed-citation><mixed-citation xml:lang="en">Duarte C, Abreu P, Couto M, et al. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage. Acta Reumatol Port. 2010 Jan-Mar;35(1):30-5.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vasquez R, Wang D, Tran Q, Adams-Huet B. A multi-center, cross-sectional study on quality of life in cutaneous lupus erythematosus patients Ann Rheum Dis. 2011 Jun;70(6):961967. doi: 10.1136/ard.2010.138792</mixed-citation><mixed-citation xml:lang="en">Vasquez R, Wang D, Tran Q, Adams-Huet B. A multi-center, cross-sectional study on quality of life in cutaneous lupus erythematosus patients Ann Rheum Dis. 2011 Jun;70(6):961967. doi: 10.1136/ard.2010.138792</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hanly J, Urowitz M, Jackson D. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis. 2011 Jun;70(6):961-7. doi: 10.1136/ard.2010.138792</mixed-citation><mixed-citation xml:lang="en">Hanly J, Urowitz M, Jackson D. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis. 2011 Jun;70(6):961-7. doi: 10.1136/ard.2010.138792</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
